121 related articles for article (PubMed ID: 10549956)
1. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.
Junor EJ; Hole DJ; McNulty L; Mason M; Young J
Br J Obstet Gynaecol; 1999 Nov; 106(11):1130-6. PubMed ID: 10549956
[TBL] [Abstract][Full Text] [Related]
2. Management of ovarian cancer: referral to a multidisciplinary team matters.
Junor EJ; Hole DJ; Gillis CR
Br J Cancer; 1994 Aug; 70(2):363-70. PubMed ID: 8054286
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery for stage IV epithelial ovarian cancer.
Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
[TBL] [Abstract][Full Text] [Related]
4. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland.
Gillis CR; Hole DJ
BMJ; 1996 Jan; 312(7024):145-8. PubMed ID: 8563532
[TBL] [Abstract][Full Text] [Related]
5. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma.
Kehoe S; Powell J; Wilson S; Woodman C
Br J Cancer; 1994 Nov; 70(5):1014-7. PubMed ID: 7947077
[TBL] [Abstract][Full Text] [Related]
6. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer: patterns of care in Victoria during 1993-1995.
Grossi M; Quinn MA; Thursfield VJ; Francis PA; Rome RM; Planner RS; Giles GG
Med J Aust; 2002 Jul; 177(1):11-6. PubMed ID: 12088472
[TBL] [Abstract][Full Text] [Related]
8. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
[TBL] [Abstract][Full Text] [Related]
9. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
[TBL] [Abstract][Full Text] [Related]
10. National guidance on gynaecological cancer management: an audit of gynaecological cancer services and management in the South East of England.
Shaw M; Wolfe C; Raju KS; Papadopoulos A
Eur J Gynaecol Oncol; 2003; 24(3-4):246-50. PubMed ID: 12807233
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.
Akahira JI; Yoshikawa H; Shimizu Y; Tsunematsu R; Hirakawa T; Kuramoto H; Shiromizu K; Kuzuya K; Kamura T; Kikuchi Y; Kodama S; Yamamoto K; Sato S
Gynecol Oncol; 2001 Jun; 81(3):398-403. PubMed ID: 11371128
[TBL] [Abstract][Full Text] [Related]
12. Advanced epithelial ovarian carcinoma: long-term survival experience at the community hospital.
Unzelman RF
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1663-71; discussion 1671-2. PubMed ID: 1615973
[TBL] [Abstract][Full Text] [Related]
13. What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer?
Woodman C; Baghdady A; Collins S; Clyma JA
Br J Obstet Gynaecol; 1997 Feb; 104(2):135-9. PubMed ID: 9070126
[TBL] [Abstract][Full Text] [Related]
14. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract][Full Text] [Related]
15. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
16. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).
Wimberger P; Wehling M; Lehmann N; Kimmig R; Schmalfeldt B; Burges A; Harter P; Pfisterer J; du Bois A
Ann Surg Oncol; 2010 Jun; 17(6):1642-8. PubMed ID: 20165986
[TBL] [Abstract][Full Text] [Related]
17. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.
Hölscher G; Anthuber C; Bastert G; Burges A; Mayr D; Oberlechner E; Schubert-Fritschle G; Sinz S; Sommer H; Schmalfeldt B; Engel J;
Acta Obstet Gynecol Scand; 2009; 88(4):440-8. PubMed ID: 19191075
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
[TBL] [Abstract][Full Text] [Related]
19. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.
Paulsen T; Kjaerheim K; Kaern J; Tretli S; Tropé C
Int J Gynecol Cancer; 2006; 16 Suppl 1():11-7. PubMed ID: 16515561
[TBL] [Abstract][Full Text] [Related]
20. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis.
Rauh-Hain JA; Gonzalez R; Bregar AJ; Clemmer J; Hernández-Blanquisett A; Clark RM; Schorge JO; Del Carmen MG
Gynecol Oncol; 2016 Jul; 142(1):38-43. PubMed ID: 27107722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
